The United Bio-technology (hengqin) Co., Ltd.

This study tests an investigational drug called UBT251 in 211 adults with type 2 diabetes who are already on metformin. The goal is to see if the drug can lower blood sugar levels over 24 weeks and to find the best dose for future studies. Participants receive either UBT251, a pl…